These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 16696075)
1. Increased expression of CD44v6 in endocrine pancreatic tumours but not in midgut carcinoid tumours. Terris B; Fléjou JF; Dubois S; Ruszniewski P; Scoazec JY; Belghiti J; Potet F; Bernades P; Mignon M; Hénin D Clin Mol Pathol; 1996 Aug; 49(4):M203-8. PubMed ID: 16696075 [TBL] [Abstract][Full Text] [Related]
2. Expression of CD44 variant isoforms and association to the benign form of endocrine pancreatic tumours. Imam H; Eriksson B; Oberg K Ann Oncol; 2000 Mar; 11(3):295-300. PubMed ID: 10811495 [TBL] [Abstract][Full Text] [Related]
3. Expression of CD44 variants in osteosarcoma. Kuryu M; Ozaki T; Nishida K; Shibahara M; Kawai A; Inoue H J Cancer Res Clin Oncol; 1999 Nov; 125(11):646-52. PubMed ID: 10541973 [TBL] [Abstract][Full Text] [Related]
4. Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors. Chaudhry A; Gobl A; Eriksson B; Skogseid B; Oberg K Cancer Res; 1994 Feb; 54(4):981-6. PubMed ID: 7508823 [TBL] [Abstract][Full Text] [Related]
5. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma. Lee LN; Kuo SH; Lee YC; Chang YL; Chang HC; Jan IS; Yang PC J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer. Kainz C; Tempfer C; Kohlberger P; Janisch S; Koelbl H; Gitsch G; Breitenecker G Int J Cancer; 1996 Jun; 69(3):170-3. PubMed ID: 8682582 [TBL] [Abstract][Full Text] [Related]
7. Expression of exon v6-containing CD44 isoforms is related to poor prognosis of acute myelocytic leukemia. Yokota A; Ishii G; Sugaya Y; Nishimura M; Saito Y; Harigaya K Hematol Oncol; 1998 Dec; 16(4):131-41. PubMed ID: 10414233 [TBL] [Abstract][Full Text] [Related]
8. Preferential histiotypic expression of CD44-isoforms in human lung cancer. Wimmel A; Schilli M; Kaiser U; Havemann K; Ramaswamy A; Branscheid D; Kogan E; Schuermann M Lung Cancer; 1997 Mar; 16(2-3):151-72. PubMed ID: 9152947 [TBL] [Abstract][Full Text] [Related]
9. Splice variants of CD44 in human cervical cancer stage IB to IIB. Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775 [TBL] [Abstract][Full Text] [Related]
11. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer. Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811 [TBL] [Abstract][Full Text] [Related]
12. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348 [TBL] [Abstract][Full Text] [Related]
13. Transient expression of CD44 variant isoforms in the ontogeny of the rat: ectoderm-, endoderm- and mesoderm-derived cells express different exon combinations. Weber B; Rösel M; Arch R; Möller P; Zöller M Differentiation; 1996 Mar; 60(1):17-29. PubMed ID: 8935925 [TBL] [Abstract][Full Text] [Related]
14. CD44 variant expression in cutaneous T-cell lymphoma. Orteu CH; Li W; Allen MH; Smith NP; Barker JN; Whittaker SJ J Cutan Pathol; 1997 Jul; 24(6):342-9. PubMed ID: 9243361 [TBL] [Abstract][Full Text] [Related]
15. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625 [TBL] [Abstract][Full Text] [Related]
16. Influence of epitopes CD44v3 and CD44v6 in the invasive behavior of fibroblast-like synoviocytes derived from rheumatoid arthritic joints. Wibulswas A; Croft D; Pitsillides AA; Bacarese-Hamilton I; McIntyre P; Genot E; Kramer IM Arthritis Rheum; 2002 Aug; 46(8):2059-64. PubMed ID: 12209509 [TBL] [Abstract][Full Text] [Related]
17. Gains and losses of CD44 expression during breast carcinogenesis and tumour progression. Bànkfalvi A; Terpe HJ; Breukelmann D; Bier B; Rempe D; Pschadka G; Krech R; Böcker W Histopathology; 1998 Aug; 33(2):107-16. PubMed ID: 9762542 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of CD44 splice variants in human stage III cervical cancer. Kainz C; Kohlberger P; Tempfer C; Sliutz G; Gitsch G; Reinthaller A; Breitenecker G Eur J Cancer; 1995 Sep; 31A(10):1706-9. PubMed ID: 7488429 [TBL] [Abstract][Full Text] [Related]
19. CD44 expression in soft tissue sarcomas. Kahara N; Ozaki T; Doi T; Nishida K; Kawai A; Shibahara M; Inoue H Virchows Arch; 2000 Jun; 436(6):574-8. PubMed ID: 10917171 [TBL] [Abstract][Full Text] [Related]
20. The prognostic value of CD44 isoform expression in endometrial cancer. Tempfer C; Haeusler G; Kaider A; Hefler L; Hanzal E; Reinthaller A; Breitenecker G; Kainz C Br J Cancer; 1998 Apr; 77(7):1137-9. PubMed ID: 9569051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]